What are the effects and benefits of budesonide nasal spray?
Budesonide nasal spray is a commonly used anti-inflammatory medication in clinical practice for the nose, with effects and benefits including reducing nasal mucosal inflammation, relieving nasal congestion, improving runny nose and sneezing, alleviating nasal and eye itching, and assisting in the treatment of nasal polyps. If symptoms do not improve or severe discomfort occurs after using the medication, prompt medical consultation is recommended.
1. Reducing nasal mucosal inflammation: As a glucocorticoid, it suppresses inflammatory responses in the nasal mucosa, reduces congestion and edema, and decreases the release of inflammatory factors, thereby addressing various discomforts caused by nasal inflammation at their source.
2. Relieving nasal congestion: By reducing swelling of the nasal mucosa, it widens the nasal passages and improves nasal airflow, making it particularly effective for persistent nasal blockage caused by allergic rhinitis or sinusitis.
3. Improving runny nose and sneezing: It inhibits the release of allergic mediators, reduces watery nasal discharge, and alleviates frequent sneezing, providing rapid relief during acute episodes of allergic rhinitis.
4. Alleviating nasal and eye itching: For nasal and periorbital itching caused by allergic rhinitis, its anti-inflammatory and antiallergic actions reduce local irritation and enhance comfort.
5. Assisting in treating nasal polyps: It helps suppress inflammatory proliferation of nasal polyp tissue, slows polyp growth, and reduces the risk of recurrence after surgery. It is often used as an adjunctive treatment following nasal polypectomy.
When using this medication, strictly follow medical instructions regarding the recommended dosage to avoid overuse. During administration, slightly tilt the head forward to ensure the medication reaches the nasal mucosa directly. Rinse the mouth with water after use. Store the product in a cool, dry place away from direct sunlight and high temperatures.
